![]() |
JOURNAL TOOLS |
Publishing options |
eTOC |
To subscribe |
Submit an article |
Recommend to your librarian |
ARTICLE TOOLS |
Reprints |
Permissions |
Share |


YOUR ACCOUNT
YOUR ORDERS
SHOPPING BASKET
Items: 0
Total amount: € 0,00
HOW TO ORDER
YOUR SUBSCRIPTIONS
YOUR ARTICLES
YOUR EBOOKS
COUPON
ACCESSIBILITY
REVIEWS
Minerva Psichiatrica 2006 March;47(1):11-24
Copyright © 2006 EDIZIONI MINERVA MEDICA
language: Italian
Neuroendocrine dysfunction in patients with mood disorders
Mazza M. 1, Bria P. 1, Janiri L. 1, Mazza S. 2
1 Istituto di Psichiatria e Psicologia Università Cattolica del Sacro Cuore, Roma 2 Istituto di Neurologia Università Cattolica del Sacro Cuore, Roma
Mood disorders represent the most widespread prevalent and expensive psychiatric disorders. For a long time, the neuroendocrine system and the distribution of hormones through the brain and their modulatory role and influence in behavior and mood have been studied. The most important changes associated with mood disorders concern the hypothalamic-pituitary-adrenal (HPA), the hypothalamic-pituitary-thyroid (HPT), the hypothalamic-pituitary-GH (HPGH) and the hypothalamic-pituitary-gonadal (HPGn) axes. The intriguing data obtained from studies focusing on central neuropeptidergic circuits and peripheral hormone systems have been very useful in understanding the pathophysiology of mood disorders, although additional researches are needed to confirm these findings. All these data underline the importance of neuroendocrine dysfunctions in both pathophysiology of mood disorders and in the development of new pharmacotherapies.